Tecan and NVIDIA advance Agentic AI for data-driven laboratories
NVIDIA-powered AI capabilities enable proactive laboratory optimization
29 Jun 2026Industry news

Tecan has integrated Agentic AI capabilities into its Introspect™ lab analytics platform, powered by the NVIDIA BioNeMo Agent Toolkit. This collaboration enables laboratories in pharmaceutical, biotechnology, and clinical environments to move from reactive monitoring to proactive, data-driven decision-making, helping prevent issues before they affect performance, quality, or scientific outcomes.
Strategic collaboration to accelerate data-driven labs
This Agentic AI development marks a key milestone in the collaboration between Tecan and NVIDIA. The joint work advances the companies’ shared vision of enabling data-driven laboratories with AI-powered platforms that accelerate scientific discovery and improve laboratory productivity.
By embedding the NVIDIA BioNeMo Agent Toolkit into Introspect, Tecan is creating a more intelligent, connected lab ecosystem that can support complex workflows, high-throughput operations, and scalable digital transformation strategies.
How Agentic AI transforms laboratory operations
Agentic AI introduces a new paradigm for laboratory operations. Instead of identifying problems only after they occur, intelligent AI agents can continuously analyze laboratory data, workflows, and system performance to uncover hidden patterns that limit throughput, constrain scalability, or reduce operational efficiency.
By transforming raw data into recommended actions, Agentic AI within Introspect enables laboratories to:
- Accelerate decision-making across research, development, and clinical workflows
- Optimize resource utilization, including instruments, consumables, and personnel
- Proactively improve overall productivity and lab uptime
- Support more consistent quality and reproducible scientific outcomes
Early access to the enhanced Introspect platform is available, with initial applications focused on pharmaceutical, biotechnology, and clinical laboratory environments where complex, data-intensive workflows demand robust automation and analytics.
Building responsible and reliable Agentic AI for the lab
The work between Tecan and NVIDIA also focuses on the agentic guardrails required for the responsible and reliable deployment of AI in laboratory environments. These safeguards are designed to support transparency, reliability, and controlled automation, helping to establish Agentic AI as a trusted technology for key research and operational workflows.
By prioritizing robust governance and clear operational boundaries, the collaboration aims to ensure that AI-driven recommendations and actions align with regulatory expectations, quality standards, and institutional policies.
Enabling next-gen lab instrumentation with Physical AI
Tecan and NVIDIA will continue to develop AI-enabled platforms that data-driven laboratories need to achieve faster discoveries and higher lab productivity. This includes the use of Physical AI to enable next-gen lab instrumentation, integrating intelligent software agents with advanced hardware to create more autonomous, efficient, and adaptable laboratory systems.
These developments are intended to support a wide range of applications, from drug discovery and bioprocessing to clinical diagnostics, by connecting data, instruments, and AI in a unified, scalable ecosystem.
Mukta Acharya, Executive Vice President - Head of the Life Sciences Business division at Tecan, said, “Agentic AI has the potential to reshape how laboratories operate. By combining Tecan’s laboratory expertise with NVIDIA’s BioNeMo Agent Toolkit, we are enabling a new generation of intelligent laboratory solutions that can proactively support scientists, improve productivity, and help accelerate scientific outcomes.”
This perspective reflects a broader industry shift toward AI-enabled, data-centric laboratories that can adapt dynamically to changing scientific and operational demands.
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>
Frequently asked questions
How does Tecan’s Introspect platform use Agentic AI and the NVIDIA BioNeMo Agent Toolkit to support data-driven laboratories?
Tecan’s Introspect lab analytics platform integrates Agentic AI powered by the NVIDIA BioNeMo Agent Toolkit to continuously analyze lab data, workflows, and system performance. This enables pharmaceutical, biotechnology, and clinical laboratories to move from reactive monitoring to proactive, data-driven decision-making, improving productivity, lab uptime, and the consistency of scientific outcomes.
What benefits does Agentic AI bring to pharmaceutical, biotechnology, and clinical laboratory operations?
Agentic AI within Tecan’s Introspect™ platform transforms raw laboratory data into recommended actions. It helps accelerate decision-making across research, development, and clinical workflows, optimize resource utilization of instruments, consumables, and personnel, and proactively improve productivity and lab uptime. These capabilities support more consistent quality and reproducible scientific outcomes in data-intensive, highly automated lab environments.
How are Tecan and NVIDIA ensuring responsible and reliable deployment of Agentic AI in laboratory environments?
Tecan and NVIDIA are developing agentic guardrails to ensure responsible and reliable AI deployment in laboratories. These safeguards focus on transparency, reliability, and controlled automation, so AI-driven recommendations and actions align with regulatory expectations, quality standards, and institutional policies. Their collaboration aims to make Agentic AI a trusted technology for key research, operational workflows, and next-generation lab instrumentation using Physical AI.